Influence of serum and albumins from different species on stability of camptothecin-loaded micelles.
暂无分享,去创建一个
Teruo Okano | Praneet Opanasopit | Masato Watanabe | T. Okano | M. Yokoyama | P. Opanasopit | Y. Maitani | K. Kawano | Masayuki Yokoyama | Kumi Kawano | Yoshie Maitani | Masato Watanabe
[1] R. Hertzberg,et al. On the mechanism of topoisomerase I inhibition by camptothecin: evidence for binding to an enzyme-DNA complex. , 1989, Biochemistry.
[2] T. Okano,et al. Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood. , 1991, Cancer research.
[3] V. Stella,et al. A kinetic and mechanistic study of the hydrolysis of camptothecin and some analogues. , 1992, Journal of pharmaceutical sciences.
[4] E K Rowinsky,et al. The current status of camptothecin analogues as antitumor agents. , 1993, Journal of the National Cancer Institute.
[5] G. Kwon,et al. Influencing factors on in vitro micelle stability of adriamycin-block copolymer conjugates , 1994 .
[6] T. Burke,et al. Differential interactions of camptothecin lactone and carboxylate forms with human blood components. , 1994, Biochemistry.
[7] T. Burke,et al. Marked interspecies variations concerning the interactions of camptothecin with serum albumins: a frequency-domain fluorescence spectroscopic study. , 1994, Biochemistry.
[8] I. Nabiev,et al. Interactions of lactone, carboxylate and self‐aggregated forms of camptothecin with human and bovine serum albumins , 1997, FEBS letters.
[9] M. Manfait,et al. Kinetics of lactone hydrolysis in antitumor drugs of camptothecin series as studied by fluorescence spectroscopy. , 1998, Biochimica et biophysica acta.
[10] T. Okano,et al. Incorporation of water-insoluble anticancer drug into polymeric micelles and control of their particle size. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[11] Y. Pommier,et al. Spectroscopic and biochemical characterisation of self-aggregates formed by antitumor drugs of the camptothecin family: their possible role in the unique mode of drug action. , 1998, Biochemical pharmacology.
[12] T. Okano,et al. Selective delivery of adriamycin to a solid tumor using a polymeric micelle carrier system. , 1999, Journal of drug targeting.
[13] B. Giovanella,et al. Dependence of Anticancer Activity of Camptothecins on Maintaining Their Lactone Function , 2000, Annals of the New York Academy of Sciences.
[14] B. Baguley,et al. Effects of protein binding on the in vitro activity of antitumour acridine derivatives and related anticancer drugs , 2000, Cancer Chemotherapy and Pharmacology.
[15] G. Kwon,et al. Micelles self-assembled from poly(ethylene oxide)-block-poly(N-hexyl stearate L-aspartamide) by a solvent evaporation method: effect on the solubilization and haemolytic activity of amphotericin B. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[16] T. Okano,et al. Incorporation of the Anticancer Agent KRN5500 into Polymeric Micelles Diminishes the Pulmonary Toxicity , 2002, Japanese journal of cancer research : Gann.
[17] Mitsuru Hashida,et al. Factors affecting drug and gene delivery: effects of interaction with blood components. , 2002, Critical reviews in therapeutic drug carrier systems.
[18] H. Maeda,et al. Macromolecular Therapeutics , 2003, Clinical pharmacokinetics.
[19] Teruo Okano,et al. Analysis of Micelle Formation of an Adriamycin-Conjugated Poly(Ethylene Glycol)–Poly(Aspartic Acid) Block Copolymer by Gel Permeation Chromatography , 1993, Pharmaceutical Research.
[20] T. Okano,et al. Polymer Design and Incorporation Methods for Polymeric Micelle Carrier System Containing Water-insoluble Anti-cancer Agent Camptothecin , 2004, Journal of drug targeting.
[21] T. Burke,et al. The Acidic Microclimate in Poly(lactide-co-glycolide) Microspheres Stabilizes Camptothecins , 1999, Pharmaceutical Research.
[22] T. Okano,et al. Block Copolymer Design for Camptothecin Incorporation into Polymeric Micelles for Passive Tumor Targeting , 2004, Pharmaceutical Research.